Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaginal oxytetracycline concentrations.

R N Thin, Z H Al Rawi, P D Simmons

    The British Journal of Venereal Diseases
    |October 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Renal function after leptospirosis.

    British medical journal·2010
    Same author

    Immunogenicity of experimental trachoma vaccines in baboons: III. Experiments with inactivated vaccines.

    The Journal of hygiene·2010
    Same author

    Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation.

    International journal of clinical pharmacology and therapeutics·2007
    Same author

    Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation.

    International journal of clinical pharmacology and therapeutics·2006
    Same author

    Ethical considerations in the early composite tissue allograft experience: a review of the Louisville Ethics Program.

    Transplantation proceedings·2005
    Same author

    The artificial heart: how close are we, and do we want to get there?

    The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2002

    Oxytetracycline concentrations in vaginal secretions exceeded the minimum inhibitory concentration for Chlamydia trachomatis. This suggests that oxytetracycline is an effective treatment for chlamydial genital infections in women.

    Area of Science:

    • Microbiology
    • Pharmacology
    • Genitourinary Medicine

    Background:

    • Tetracycline use is common in genitourinary medicine, but concentrations in genital secretions are poorly understood.
    • Understanding drug concentrations is crucial for effective treatment of sexually transmitted infections.

    Purpose of the Study:

    • To measure oxytetracycline concentrations in vaginal secretions.
    • To determine if these concentrations are sufficient to treat Chlamydia trachomatis infections.

    Main Methods:

    • A microbiological assay was employed to quantify oxytetracycline levels.
    • Vaginal secretions were collected from women undergoing treatment.

    Main Results:

    • Oxytetracycline concentrations ranged from 0.6 to 6.5 microgram/ml.

    Related Experiment Videos

  • These levels were significantly higher than the minimum inhibitory concentration (0.2 microgram/ml) for Chlamydia trachomatis.

    • Conclusions:

    • The dosage of oxytetracycline 250 mg four times daily achieved therapeutic concentrations in vaginal secretions.
    • This regimen appears satisfactory for treating chlamydial genital infections in women.